Sun On Progressing Antibe’s Non-Opioid Analgesic, Challenges In Japan
Sun Scion Elevated As COO
Sun Pharma sees opportunities for Antibe’s otenaproxesul in the US and emerging markets and aims to get the clinical hold on the novel NSAID lifted. The firm is also focusing on its specialty business in Japan, amid pricing challenges for long-listed products.
